SCHEMBL21757546

SCHEMBL21757546

Cc1cc(C)n2ccc(C(=O)NC3CCC3)c2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
KDM4E B2RXH2 4/20 0.59
POLB P06746 3/20 0.59
RAB9A P51151 2/20 0.50
HPGD P15428 3/20 0.49
ATM Q13315 1/20 0.46
MAPT P10636 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HSD17B10 Q99714 2/20 0.46
TSHR P16473 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
CNR2 P34972 1/20 0.44
SPR P35270 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
LMNA P02545 1/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18356836 0.96 ALDH1A1 (0.64) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL23511774 0.96 ALDH1A1 (0.64) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL20353021 0.96 ALDH1A1 (0.64) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL19368286 0.96 ALDH1A1 (0.64) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL20353019 0.96 ALDH1A1 (0.64) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL20353085 0.90 ALDH1A1 (0.57) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL17743056 0.90 ALDH1A1 (0.49) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL20337386 0.90 ALDH1A1 (0.49) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL22754745 0.89 ALDH1A1 (0.50) ALDH1A1KDM4EPOLBRAB9AHPGD
SCHEMBL18357161 0.89 POLR1A (0.54) ALDH1A1KDM4EPOLBRAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3215509-B1 SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS INC (US) 2020-02-26 EP disclosed